Bradley Shapiro, MD, a gastroenterologist with Duly Health and Care, has been named a 2026 Castle Connolly Top Doctor, marking the second consecutive year he has received this distinguished recognition. This designation places him among an elite group of physicians, as only 7 percent of the nation's licensed physicians are selected annually as Castle Connolly Top Doctors for their specialties in their respective regions.
The importance of this recognition extends beyond individual achievement, serving as a valuable indicator for patients seeking high-quality gastrointestinal care. Castle Connolly's rigorous selection process involves peer nominations followed by evaluation by the physician-led research team, which examines medical education, training, hospital appointments, and disciplinary histories. This vetting process provides patients with reliable information when making critical healthcare decisions, particularly for complex digestive conditions that require specialized expertise.
Dr. Shapiro's recognition carries significant implications for patient care in the suburban Chicago area, where he has provided specialized gastrointestinal services for over two decades. His medical focus includes the management of esophageal and swallowing disorders such as GERD, Barrett's esophagus, and eosinophilic esophagitis, along with colorectal screening and surveillance. He also addresses complex inflammatory bowel diseases including Crohn's disease and ulcerative colitis, conditions that affect millions of Americans and require ongoing, specialized management.
The practical impact of this recognition is evident in Dr. Shapiro's procedural expertise, which includes colonoscopy with polyp resection, upper endoscopy (EGD), dilation for esophageal strictures, and esophageal pH and motility studies. These diagnostic and therapeutic procedures are essential for early detection and treatment of gastrointestinal cancers and other serious digestive disorders. Patients benefit from knowing they are receiving care from a physician whose skills have been validated through peer recognition and rigorous evaluation.
Dr. Shapiro's contributions to medical research further underscore the significance of this recognition. He has published in several peer-reviewed journals, including the American Journal of Gastroenterology and Modern Pathology, with research focusing on p53 suppressor gene mutations as markers for cancer in ulcerative colitis. This scientific work has implications for improving cancer detection and treatment outcomes for patients with chronic digestive conditions.
The selection process for Castle Connolly Top Doctors, detailed at https://www.castleconnolly.com, ensures that physicians cannot pay for inclusion, maintaining the integrity of the recognition. This transparency matters to healthcare consumers who increasingly seek objective information when selecting medical providers. For patients with gastrointestinal concerns, Dr. Shapiro's repeated recognition provides assurance of consistent excellence in clinical care, research contributions, and professional standing within the medical community.
